Total nutrient admixtures appear safer than lipid emulsion alone as regards microbial contamination: growth properties of microbial pathogens at room temperature.

BACKGROUND The extraordinary growth properties of most microorganisms in 10% and 20% lipid emulsions has led to the Centers for Disease Control and Prevention recommendation that if lipids are given through an i.v. line, the administration set should be replaced every 24 hours rather than the usual 72-hour interval used for crystalloid solutions, including those used for conventional total parenteral nutrition. For nearly 15 years, parenteral alimentation has been given as a total nutrient admixture (TNA), with the glucose, amino acids, and lipid mixed within the same bag and infused continuously over 24 hours. METHODS We prospectively studied in a representative TNA (17.6% glucose, 5% amino acids, 4% lipid; pH 5.6, osmolality 1778) and in a control solution, 5% dextrose-in-water (D5%/W), the growth properties at 4, 25, and 35 degrees C of three isolates each of Staphylococcus epidermidis, Staphylococcus aureus, Enterobacter cloacae, Klebsiella oxytoca, Serratia marcescens, Acinetobacter calcoaceticus, Stenotrophomonas maltophilia, Pseudomonas aeruginosa, Burkholderia cepacia, Flavobacterium spp, and Candida albicans, and two isolates of Staphylococcus saprophyticus, the species that are most likely to contaminate TNA during preparation or administration and that have been implicated in >95% of all outbreaks and sporadic cases of nosocomial bloodstream infections traced to contaminated parenteral admixtures reported in the world literature. RESULTS Growth in TNA at 25 and 35 degrees C occurred with only two species, C. albicans and S. saprophyticus, and only after 24 to 48 hours; D5%/W allowed growth at 25 degrees C of two gram-negative species, S. marcescens and B. cepacia. CONCLUSIONS We conclude that TNA is a poor growth medium for most nosocomial pathogens and is no better than D5%/W. The need to replace administration sets every 24 hours with TNA should be reconsidered and ideally be studied in a prospective randomized trial.

[1]  M. Pearson Guideline for Prevention of Intravascular-Device–Related Infections , 1996, Infection Control & Hospital Epidemiology.

[2]  D M Perrotta,et al.  Postoperative infections traced to contamination of an intravenous anesthetic, propofol. , 1995, The New England journal of medicine.

[3]  J. L. Pérez,et al.  Staphylococcus saprophyticus sepsis related to total parenteral nutrition admixtures contamination. , 1993, JPEN. Journal of parenteral and enteral nutrition.

[4]  T. Gillespie,et al.  Growth of micro‐organisms in solutions of intravenous anaesthetic agents , 1993, Anaesthesia.

[5]  R. Gilsdorf,et al.  Effect of the Mode of Lipid Administration on Parenteral Nutrition-Related Infections , 1992, The Annals of pharmacotherapy.

[6]  S. McAllister,et al.  Microbial Growth and Endotoxin Production in the Intravenous Anesthetic Propofol , 1991, Infection Control & Hospital Epidemiology.

[7]  X. Le Coutour,et al.  Septicemia caused by contaminated parenteral nutrition pouches: the refrigerator as an unusual cause. , 1991, JPEN. Journal of parenteral and enteral nutrition.

[8]  M. Moro,et al.  Nosocomial outbreak of systemic candidosis associated with parenteral nutrition. , 1990 .

[9]  D. Maki The use of antiseptics for handwashing by medical personnel. , 1989, Journal of chemotherapy.

[10]  K. Apelgren,et al.  Answering the fat emulsion contamination question: three in one admixture vs conventional total parenteral nutrition in a clinical setting. , 1988, JPEN. Journal of parenteral and enteral nutrition.

[11]  J. Lawrence,et al.  MICROBIAL CONTAMINATION AND GROWTH IN TOTAL PARENTERAL NUTRITION SOLUTIONS , 1988, Journal of clinical pharmacy and therapeutics.

[12]  D. Maki,et al.  Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals. 72 hours is safe and cost-effective. , 1987, JAMA.

[13]  J. Klimek,et al.  The growth of microorganisms in total parenteral nutrition admixtures. , 1987, JPEN. Journal of parenteral and enteral nutrition.

[14]  J. Martinoff,et al.  Growth of Microorganisms in Total Nutrient Admixtures , 1987, Drug intelligence & clinical pharmacy.

[15]  P. Davis,et al.  Contamination rates of 3-in-1 total parenteral nutrition in a clinical setting. , 1987, JPEN. Journal of parenteral and enteral nutrition.

[16]  D. Snydman,et al.  Intravenous Tubing Containing Burettes Can Be Safely Changed at 72 Hour Intervals , 1987, Infection Control.

[17]  R. Sigman,et al.  Total nutrient admixture: a review. , 1986, JPEN. Journal of parenteral and enteral nutrition.

[18]  J. Lemons,et al.  Bacterial/fungal growth in a combined parenteral nutrition solution. , 1986, JPEN. Journal of parenteral and enteral nutrition.

[19]  S. Gallagher,et al.  Microbial growth patterns in a total parenteral nutrition formulation containing lipid emulsion. , 1986, JPEN. Journal of parenteral and enteral nutrition.

[20]  L. Ayers,et al.  Growth of bacteria and fungi in total nutrient admixtures. , 1986, American journal of hospital pharmacy.

[21]  W. Williams,et al.  Infection control during parenteral nutrition therapy. , 1985, JPEN. Journal of parenteral and enteral nutrition.

[22]  M. F. Sierra,et al.  The Relationship Between Intravenous Fluid Contamination and the Frequency of Tubing Replacement , 1985, Infection Control.

[23]  E. Jaurrieta,et al.  Hub colonization as the initial step in an outbreak of catheter-related sepsis due to coagulase negative staphylococci during parenteral nutrition. , 1984, JPEN. Journal of parenteral and enteral nutrition.

[24]  W. Steffee,et al.  Microbial growth comparisons of five commercial parenteral lipid emulsions. , 1984, JPEN. Journal of parenteral and enteral nutrition.

[25]  D. Snydman,et al.  Intravenous tubing with burettes can be safely changed at 48-hour intervals. , 1984, JAMA.

[26]  W. Jarvis,et al.  Bacterial growth and endotoxin production in lipid emulsion , 1984, Journal of clinical microbiology.

[27]  R. H. Parker,et al.  An outbreak of Candida parapsilosis bloodstream infections in patients receiving parenteral nutrition. , 1984, The Journal of infectious diseases.

[28]  C. Mayhall,et al.  Microbial growth patterns in intravenous fat emulsions. , 1983, American journal of hospital pharmacy.

[29]  James R. Allen,et al.  Polymicrobial bacteremia associated with lipid emulsion in a neonatal intensive care unit , 1983, Pediatric infectious disease.

[30]  James R. Allen,et al.  Guidelines for Prevention of Intravascular Infections , 1982, Infection Control.

[31]  D. Maki,et al.  Safety of changing intravenous delivery systems at longer than 24-hour intervals. , 1979, Annals of internal medicine.

[32]  W. Schaffner,et al.  Gram-negative bacillary sepsis associated with use of lipid emulsion in parenteral nutrition. , 1979, American journal of diseases of children.

[33]  A. Buxton,et al.  Contamination of intravenous infusion fluid: effects of changing administration sets. , 1979, Annals of internal medicine.

[34]  D. G. Brown,et al.  Nosocomial outbreak of Candida parapsilosis fungemia related to intravenous infusions. , 1977, Archives of internal medicine.

[35]  D. Maki Growth properties of microorganisms in infusion fluid and methods of detection , 1976 .

[36]  D. Maki Sepsis arising from extrinsic contamination of the infusion and measures for control , 1976 .

[37]  W. Schaffner,et al.  Microbiol growth in lipid emulsions used in parenteral nutrition. , 1975, Archives of surgery.

[38]  D. Maki,et al.  Nationwide epidemic of septicemia caused by contaminated infusion products. IV. Growth of microbial pathogens in fluids for intravenous infusions. , 1975, The Journal of infectious diseases.

[39]  D. Goldmann,et al.  Growth of bacteria and fungi in total parenteral nutrition solutions. , 1973, American journal of surgery.